Wordt geladen...
The emerging potential for network analysis to inform precision cancer medicine
Precision cancer medicine promises to tailor clinical decisions to patients using genomic information. Indeed, successes of drugs targeting genetic alterations in tumors, such as imatinib that targets BCR-ABL in chronic myelogenous leukemia, have demonstrated the power of this approach. However biol...
Bewaard in:
| Gepubliceerd in: | J Mol Biol |
|---|---|
| Hoofdauteurs: | , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6097914/ https://ncbi.nlm.nih.gov/pubmed/29908887 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jmb.2018.06.016 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|